Description
IGF-1 LR3 1mg — IGF receptor signalling and binding-protein interactions.
IGF-1 LR3 1mg is an analogue of insulin-like growth factor 1 studied in receptor-signalling and cell-biology experiments. LR3 refers to structural modifications that distinguish it from native IGF-1.
What the Research Shows
Primary research compared Long R3 IGF-I with other IGF analogues and examined interactions with IGF-binding proteins. The altered binding profile is one reason this analogue is studied in experimental systems. Findings depend on the cell type, assay and conditions used; they do not establish human performance or muscle-growth benefits. See the Long R3 IGF-I analogue research for the original context.
IGF-1 LR3 1mg Product Details
- Product: IGF-1 LR3 1mg
- Labelled amount: 1 mg per vial
- Research context: IGF receptor signalling and binding-protein interactions
- Product code: IGFLR3-1
Batch-specific identity and analytical specifications should be checked against the matching supplier documentation. Published research describes the authors’ materials and methods; it is not a certificate of analysis for this product.
Related Research Resources
Explore the Purpose Labs research library for further background. Related catalogue entries include Tesamorelin 10mg and Ipamorelin 10mg. These are separate compounds with their own research profiles.
For research use only. Not for human consumption.




